- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
Orgenesis Stock (NASDAQ:ORGS), Quotes and News Summary
Orgenesis Stock (NASDAQ: ORGS)
| Day Range1.45 - 1.55 | 52 Wk Range1.57 - 4.04 | Open / Close1.55 / 1.5 | Float / Outstanding25.2M / 25.5M |
| Vol / Avg.21.8K / 32.2K | Mkt Cap38.3M | P/E- | 50d Avg. Price1.86 |
| Div / Yield- | Payout Ratio- | Total Float25.2M | EPS-0.22 |
Earnings
see more| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-11-03 | ||||||
| REV | |||||||
| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.220 | ||||||
| REV | 7.000M | 7.201M | 201.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Orgenesis Questions & Answers
You can purchase shares of Orgenesis (NASDAQ: ORGS) through any online brokerage.
Other companies in Orgenesis’s space includes: Acurx Pharmaceuticals (NASDAQ:ACXP), Gain Therapeutics (NASDAQ:GANX), Ambrx Biopharma (NYSE:AMAM), Celyad Oncology (NASDAQ:CYAD) and Galera Therapeutics (NASDAQ:GRTX).
The latest price target for Orgenesis (NASDAQ: ORGS) was reported by Benchmark on Thursday, September 26, 2019. The analyst firm set a price target for 9.00 expecting ORGS to rise to within 12 months (a possible 500.00% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Orgenesis (NASDAQ: ORGS) is $1.5 last updated September 23, 2022, 8:00 PM UTC.
There are no upcoming dividends for Orgenesis.
Orgenesis’s Q3 earnings are confirmed for Thursday, November 3, 2022.
There is no upcoming split for Orgenesis.
Orgenesis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.